mous
hepat
viru
mhv
induc
autoantibodi
autoab
fumarylacetoacet
hydrolas
fah
solubl
cytosol
enzym
present
liver
kidney
variou
mous
strain
aim
work
amplifi
diversifi
autoimmun
respons
restrict
fah
use
exogen
adjuv
call
padr
accordingli
mice
chosen
anim
respond
padr
better
mous
strain
result
present
herein
indic
surprisingli
mice
develop
sign
autoimmun
hepatitislik
diseas
aih
includ
transient
hypergammaglobulinemia
elev
transaminas
autoab
direct
differ
liver
protein
hepat
cellular
infiltr
indic
new
model
experiment
aih
could
gener
viral
inocul
furthermor
padr
administr
amplifi
mhv
effect
extend
durat
hypergammaglobulinemia
increas
bind
autoab
well
degre
hepat
infiltr
howev
adjuv
expand
time
symptom
addit
sinc
plasmat
uric
acid
highmobl
group
box
protein
concentr
augment
mhvandor
padretr
mice
suggest
alarmin
probabl
involv
spread
immun
respons
induc
viral
infect
adjuv
administr
autoimmun
hepat
aih
progress
chronic
condit
immun
system
attack
liver
caus
inflamm
liver
cell
death
human
aih
character
presenc
interfac
hepat
portal
plasma
cell
infiltr
hypergammaglobulinemia
increas
serum
transaminas
autoantibodi
autoab
liver
antigen
ag
like
autoimmun
diseas
disord
result
complex
interact
trigger
factor
viral
infect
genet
predisposit
immunoregulatori
network
anim
model
aih
could
use
provid
inform
mechan
liver
protect
immun
attack
variou
trigger
agent
disrupt
immun
toler
besid
get
insight
mechan
could
lead
prevent
therapeut
measur
thu
present
paper
report
result
obtain
hepatotrop
viru
mous
hepat
viru
suscept
mous
strain
immun
strong
cell
stimul
padr
pan
hladr
bind
epitop
coronaviru
caus
variou
mous
patholog
includ
hepat
thymu
involut
hypergammaglobulinaemia
transient
demyelin
report
presenc
autoantibodi
autoab
fumarylacetoacet
hydrolas
fah
sera
variou
mous
strain
mhv
infect
autoab
recogn
conform
well
linear
antigen
determin
enzym
autoimmun
respons
partli
relat
molecular
mimicri
furthermor
shown
induct
antifah
autoab
associ
mhvinduc
releas
danger
signal
also
call
damp
damageassoci
molecular
pattern
alarmin
recent
work
inocul
balbc
mice
carbon
tetrachlorid
ccl
day
mhv
infect
autoab
total
ig
assay
serum
day
later
associ
mhv
infect
toxic
effect
ccl
result
hypergammaglobulinemia
product
autoab
variou
liver
kidney
protein
liver
histolog
show
sever
patholog
chang
without
cellular
infiltr
character
aih
improv
previou
experiment
model
aihlik
diseas
herein
use
synthet
peptid
padr
inject
togeth
viru
mice
chosen
rather
balbc
strain
known
better
respond
padr
mous
strain
present
result
indic
first
mhvinfect
mice
develop
sever
sign
aih
ie
hypergammaglobulinaemia
autoab
liver
antigen
ag
elev
transaminas
intern
immunopharmacolog
intern
immunopharmacolog
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
ev
e
r
c
l
c
e
n
p
interestingli
liver
infiltr
addit
simultan
treatment
padr
amplifi
sign
aihlik
diseas
specificpathogenfre
spf
femal
mice
univers
la
plata
argentina
use
age
week
anim
maintain
isol
standard
laboratori
chow
spf
condit
end
experi
receiv
care
complianc
intern
legal
requir
nctc
adher
cell
line
deriv
normal
mous
liver
purchas
american
type
cultur
collect
cell
grow
bottl
inocul
mhv
viru
multipl
tcid
cell
adsorpt
period
h
ml
nctc
medium
fetal
calf
serum
ad
bottl
incub
sever
cycl
freez
thaw
use
releas
viru
h
inocul
harvest
viru
centrifug
g
min
remov
debri
supernat
frozen
storag
viru
titrat
endpoint
method
perform
inocul
serial
dilut
mhv
stock
onto
cell
monolay
plate
h
well
viral
cytopath
effect
count
dilut
titer
express
tissu
infecti
dose
tcid
twelv
mice
inocul
subcutan
pb
dilut
complet
freund
adjuv
sigmaaldrich
inc
illinoi
mo
usa
mice
call
padr
latter
h
mice
infect
intraperiton
tcid
anim
mhv
padr
control
third
group
mice
infect
viru
mhv
mice
mice
bled
day
infect
total
igg
determin
mous
serum
elisa
micropl
corn
incorpor
corn
ny
usa
coat
phosphat
buffer
salin
pb
contain
dilut
rabbit
antiserum
direct
mous
ig
plate
block
h
tri
nacl
ph
tm
contain
nonfat
milk
tmsm
incub
serial
dilut
mous
serum
medium
h
wash
pb
contain
ml
tween
per
liter
pbstween
plate
incub
h
peroxidaselabel
antimous
igg
ab
peroxidaselabel
goat
antimous
igg
santa
cruz
biotechnolog
ca
usa
use
dilut
tmsm
sequenc
peptid
padr
singl
letter
code
ak
x
vaawtlkaa
x
lcyclohexylalanin
damino
acid
design
lowercas
letter
ctermin
amid
peptid
synthesi
perform
solid
phase
fmoc
methodolog
mmol
scale
peptid
assembl
automat
peptid
synthes
model
appli
biosystem
inc
foster
citi
ca
usa
fmoc
amino
acid
peptid
intern
louisvil
ky
usa
incorpor
onto
rink
amidepmethyl
pbenzhydrylamin
resin
peptid
intern
inc
louisvil
kentucki
usa
hydroxybenzotriazol
activ
ester
fmoc
protect
group
remov
piperidin
nmethylpyrrolidon
nmp
peptid
cleavag
resin
achiev
trifluoracet
acid
tfa
ethanedithiolwat
vv
h
room
temperatur
suspens
resin
filter
crude
materi
precipit
ad
ml
cold
diethyl
ether
wash
three
time
diethyl
ether
residu
ether
remov
evapor
reduc
pressur
peptid
lyophil
crude
peptid
materi
purifi
high
perform
liquid
chromatographi
hplc
vydac
semi
prepar
column
cm
separ
group
hesperia
ca
usa
elut
linear
acetonitril
gradient
presenc
tfa
min
mlmin
main
peak
collect
lyophil
repurifi
column
peptid
puriti
verifi
amino
acid
analysi
sequenc
determin
mass
spectrometri
perform
lanaispro
nation
protein
sequenc
facil
ubaconicet
bueno
air
argentina
essenti
method
describ
ball
et
al
use
elisa
plate
corn
incorpor
corn
ny
usa
coat
polyllysin
kda
sigmaaldrich
inc
illinoi
mo
usa
contain
sodium
bicarbon
buffer
ph
h
room
temperatur
wash
pb
vv
glutaraldehyd
ad
well
plate
wash
min
incub
peptid
padr
dilut
concentr
pb
ad
well
coat
polyllysin
activ
glutaraldehyd
plate
incub
overnight
room
temperatur
wash
twice
pb
reactiv
aldehyd
site
block
addit
glycin
follow
incub
h
room
temperatur
wash
plate
incub
overnight
room
temperatur
mous
serum
dilut
tri
nacl
ph
contain
nonfat
milk
tbsm
wash
pb
contain
ml
tween
per
liter
pbstween
bound
ab
reveal
peroxidaselabel
goat
antimous
igg
santa
cruz
biotechnolog
ca
usa
dilut
tbsm
substrat
orthophenylenediaminedihydrochlorid
opd
sigma
chemic
co
st
loui
mo
usa
freshli
ad
h
use
reaction
stop
min
addit
h
absorpt
measur
elisa
reader
metertech
inc
taipei
taiwan
nm
nonspecif
valu
optic
densiti
obtain
absenc
mous
serum
liver
noninfect
mice
remov
soak
chill
pb
ground
omni
mixer
homogen
omni
intern
inc
usa
volum
pb
contain
mm
phenylmethylsulfonyl
fluorid
pmsf
uml
trypsin
inhibitor
homogen
centrifug
min
g
clarifi
extract
kept
use
sampl
suspens
solubil
heat
min
naoh
protein
concentr
determin
method
lowri
et
al
enzym
prepar
previous
describ
briefli
liver
wistar
rat
homogen
vol
vw
chill
sucros
mm
trishcl
buffer
contain
mm
cacl
uml
trypsin
inhibitor
mm
pmsf
ph
centrifug
g
min
g
h
ethyl
alcohol
ad
supernat
obtain
final
concentr
ethanol
mixtur
allow
stand
overnight
centrifug
g
min
supernat
mix
ethyl
alcohol
yield
final
alcohol
concentr
incub
overnight
precipit
enzym
pack
centrifug
g
min
pellet
resuspend
mm
phosphat
buffer
ph
stir
min
supernat
fluid
recov
centrifug
suspens
g
min
solid
ammonium
sulfat
ad
obtain
final
salt
concentr
h
centrifug
g
min
pellet
resuspend
mm
trishcl
ph
dialyz
buffer
liver
extract
protein
purifi
fah
protein
submit
sdspage
transfer
onto
nitrocellulos
sheet
amersham
buckinghamshir
uk
revers
stain
ponceau
check
satisfactori
transfer
nonspecif
abbind
site
block
incub
sheet
nonfat
milk
mm
tri
nacl
vv
tween
ph
tbsmt
h
room
temperatur
shake
strip
incub
overnight
ab
dilut
tbsmt
sever
wash
tb
contain
tween
bound
ab
reveal
peroxidaselabel
goat
antimous
igg
igpo
santa
cruz
biotechnolog
ca
usa
dilut
tbsmt
ecl
plu
reagent
amersham
buckinghamshir
uk
everi
experi
neg
control
pool
sera
mice
use
afterward
posit
control
pool
sera
mhvinfect
mice
includ
appar
molecular
mass
kda
detect
band
determin
use
wide
rang
protein
standard
bdh
laboratori
suppli
pool
uk
fah
protein
dilut
tri
nacl
ph
tb
place
contain
protein
nitrocellulos
paper
use
biodot
equip
biorad
laboratori
hercul
ca
usa
membran
block
incub
h
tri
nacl
ph
tb
contain
nonfat
milk
vv
tween
tbsmt
wash
tb
contain
vv
tween
tbst
remov
excess
protein
membran
incub
overnight
indic
serum
dilut
wash
tbst
incub
h
dilut
igpo
tbsmt
four
wash
tbst
bound
ab
detect
chemiluminesc
reaction
ecl
plu
amersham
buckinghamshir
uk
fluoresc
subsequ
captur
radiograph
film
frame
xray
exposur
film
immers
develop
solut
min
eastman
kodak
compani
new
york
usa
rins
water
treat
min
develop
solut
eastman
kodak
compani
new
york
usa
quantifi
intens
band
obtain
use
gel
pro
analyz
program
media
cybernet
inc
silver
spring
md
usa
mous
sera
filter
centricon
millipor
corp
usa
clear
sampl
macromolecular
complex
concentr
centricon
separ
sdspolyacrilamid
gel
western
blot
analysi
carri
describ
identifi
mab
santa
cruz
biotechnolog
ca
usa
dilut
peroxidaselabel
goat
antimous
igg
recombin
human
hmgbiotech
srl
milano
itali
use
posit
control
liver
mhv
mhv
padr
control
mice
treatment
cut
block
fix
immers
formalin
phosphat
buffer
ph
fixat
tissu
dehydr
grade
alcohol
embed
paraffin
section
cut
stain
harri
hematoxylin
min
counterstain
eosin
min
section
wash
distil
water
dehydr
grade
alcohol
xylen
mount
canada
balsam
serum
aspart
aminotransferas
ast
determin
use
got
ast
unitest
wiener
lab
rosario
argentina
uric
acid
concentr
determin
enzymat
use
assay
kit
uricostat
wiener
lab
rosario
argentina
dilut
mous
sera
liver
extract
indic
manufactur
liver
extract
ml
prepar
indic
except
control
sera
untreat
mice
distil
water
use
instead
pb
suspens
centrifug
twice
min
g
expect
sinc
mhv
produc
hypergammaglobulinemia
higher
ig
level
found
sera
mhv
mhv
padr
mice
control
day
postinfect
ig
concentr
decreas
normal
valu
day
fig
padr
inocul
also
caus
signific
increas
ig
control
day
posttreat
fig
moreov
valu
serum
ig
concentr
significantli
higher
serum
mhv
padr
mhv
anim
day
treatment
fig
posit
variou
band
autoag
detect
western
blot
assay
rel
mobil
rm
calcul
accord
mobil
relat
endogen
igg
heavi
light
chain
locat
arbitrari
valu
respect
fig
antifah
autoab
detect
sera
mhv
mhv
padr
mice
test
time
previous
describ
balbc
cbaht
mice
infect
mhv
fig
unexpectedli
addit
antifah
autoab
mice
use
studi
produc
ab
liver
protein
differ
molecular
weight
either
mhv
infect
alon
mhv
infect
togeth
padr
treatment
even
mice
treat
padr
alon
produc
autoab
variou
liver
protein
see
repres
result
fig
wherea
sera
mice
inocul
complet
freund
adjuv
alon
react
data
shown
whole
result
present
individu
valu
rm
indic
autoab
padr
anim
detect
similar
number
band
correspond
liver
autoag
day
treatment
band
respect
decreas
ab
reactiv
day
band
fig
describ
mice
inocul
mhv
develop
autoab
protein
fah
fig
number
band
detect
exclud
fah
higher
day
band
day
band
respect
similarli
ab
mhv
padr
anim
detect
highest
number
autoag
band
day
wherea
day
posttreat
seven
band
obtain
fig
sinc
western
blot
result
show
higher
intens
autoab
reactiv
sera
mhv
padr
mice
padr
mhv
anim
fig
measur
reactiv
autoab
specif
fah
western
blot
analys
indic
reactiv
antifah
autoab
increas
sera
mhv
padr
compar
valu
mhv
mice
day
postinfect
fig
ident
result
obtain
sera
day
treatment
data
shown
western
blot
condit
protein
mostli
denatur
antifah
autoab
would
recogn
mainli
linear
andor
cryptic
epitop
protein
thu
determin
autoab
reactiv
toward
nativ
conform
epitop
enzym
dot
blot
assay
use
result
indic
bind
reactiv
antifah
ab
higher
sera
mhv
padr
mhv
mice
day
treatment
fig
wherea
differ
detect
sampl
taken
day
posttreat
data
shown
antipadr
ab
titer
express
serum
dilut
obtain
od
similar
nontreat
mhvinfect
mice
rang
day
posttreat
tabl
hand
ab
titer
padr
anim
rais
day
respect
wherea
found
mhv
padr
mice
three
bleed
time
test
tabl
autoab
liver
tissu
padr
mhv
padr
mice
could
due
possibl
crossreact
antipadr
ab
varieti
liver
protein
howev
highest
titer
ab
padr
found
day
postinfect
either
padr
mhv
padr
mice
tabl
wherea
autoab
liver
protein
abund
day
fig
suggest
lack
correl
find
probabl
absenc
crossreact
antipadr
ab
liver
protein
padr
anim
show
elev
level
enzym
time
treatment
tabl
contrast
mhv
mhv
padr
mice
display
signific
higher
ast
serum
level
control
day
postinfect
wherea
valu
day
similar
found
nontreat
anim
tabl
uric
acid
potent
alarmin
damp
damageassoci
molecular
pattern
endogen
adjuv
follow
releas
four
mous
group
singl
inocul
padr
significantli
increas
serum
uric
acid
control
valu
day
posttreat
tabl
c
besid
mhv
mice
show
elev
uric
acid
concentr
sera
obtain
day
viru
inocul
wherea
serum
mhv
padr
anim
uric
acid
level
higher
control
day
postinfect
also
measur
uric
acid
concentr
hepatocyt
extract
four
mice
day
treatment
follow
result
obtain
mgg
control
mgg
padr
anim
mgg
p
b
mhv
mice
mgg
p
b
mhv
padr
mice
note
day
level
uric
acid
significantli
increas
serum
mhv
padr
mice
wherea
clearli
elev
hepatocyt
extract
alarmin
undetect
sera
four
group
postinfect
posttreat
level
strongli
increas
day
mhv
mhv
padr
even
padr
group
tabl
liver
section
control
anim
contain
small
foci
lymphocyt
neutrophil
although
sampl
show
cellular
injuri
fig
liver
mhv
mice
exhibit
sever
damag
control
edema
necrosi
hepatocyt
signific
infiltr
lymphocyt
neutrophil
mainli
day
postinfect
fig
liver
mhv
padr
mice
show
abund
foci
cellular
infiltr
day
postinfect
suggest
padr
aggrav
degre
patholog
induc
viru
fig
fibrosi
observ
group
anim
model
aih
induc
variou
mechan
includ
xenoimmun
human
antigen
adenoviru
vector
transgenesi
polyclon
activ
cell
inocul
concanavalin
model
liver
damag
observ
condit
elev
transaminas
howev
ab
liver
protein
direct
immunogen
neither
high
ig
plasmat
level
report
addit
model
describ
transient
sinc
mechan
critic
perpetu
liver
damag
still
unknown
review
see
ref
besid
recent
found
simpl
common
phenomenon
ie
viral
infect
induc
autoab
autolog
protein
follow
toxic
liver
injuri
could
induc
sign
aih
propos
releas
greater
amount
alarmin
could
induc
expans
autoimmun
respons
establish
patholog
resembl
aih
purpos
present
work
establish
better
model
experiment
aihlik
diseas
use
mhvinfect
mice
simultan
treat
peptid
univers
lymphocyt
epitop
padr
could
amplifi
diversifi
autoimmun
respons
induc
viru
restrict
fah
mous
strain
stress
mice
infect
mhv
found
behav
differ
mous
strain
inde
balbc
cbaht
mice
viral
infect
autoantibodi
restrict
fah
wherea
infect
mice
develop
autoantibodi
multipl
liver
antigen
furthermor
sera
mice
inocul
padr
alon
also
show
autoab
liver
protein
princip
day
posttreat
mhv
padr
group
autoab
abund
diversifi
specif
padr
anim
addit
western
blot
dot
blot
assay
prove
autoab
induc
mhv
padr
mice
bind
fah
protein
stronger
found
mhv
anim
ab
mhv
padr
anim
mainli
direct
nativ
epitop
enzym
indic
padr
adjuv
influenc
bcell
respons
induct
autoab
detect
group
padr
mhv
padr
could
relat
presenc
antipadr
ab
possibl
crossreact
liver
protein
antipadr
ab
test
elisa
expect
antipadr
ab
detect
control
mhv
anim
although
autoab
liver
protein
found
latter
moreov
antipadr
ab
peak
day
postinfect
posttreat
group
padr
mhv
padr
wherea
autoab
liver
protein
peak
day
indic
antipadr
ab
autoab
differ
kinet
probabl
unrel
antigen
specif
patholog
featur
liver
mice
submit
variou
treatment
indic
control
mice
present
small
cellular
infiltr
observ
previous
balbc
mice
come
facil
spite
observ
mhv
andor
padr
inocul
worsen
condit
sinc
import
infiltr
observ
mainli
mhv
padr
anim
injur
hepatocyt
liber
transaminas
indic
elev
concentr
enzym
day
postinfect
although
intriguingli
plasmat
valu
similar
control
day
treatment
uric
acid
one
studi
alarmin
increas
serum
padr
anim
time
test
wherea
level
mhv
augment
day
treatment
furthermor
uric
acid
concentr
higher
control
day
viral
infect
mhv
padr
mice
one
could
specul
plasmat
uric
acid
mhv
padr
mice
day
treatment
similar
control
lower
valu
found
mhv
anim
due
urat
crystal
retent
within
hepatocyt
fact
uric
acid
concentr
test
whole
liver
tissu
day
treatment
result
show
ident
valu
mhv
mhv
padr
anim
hand
serum
concentr
significantli
augment
time
three
anim
group
even
padr
mice
padr
present
mhc
class
ii
molecul
expect
act
helper
cell
indirectli
b
cell
consequ
effect
padr
releas
alarmin
unexpectedli
intrigu
found
uric
acid
level
present
plasma
padr
anim
elev
hepatocyt
extract
origin
alarmin
probabl
hepatocyt
perhap
stimul
lymphocyt
non
antigenspecif
leucocyt
one
also
specul
padr
recogn
prr
patternrecogn
receptor
tolllik
receptor
nodlik
receptor
fact
knowledg
report
far
liver
known
classic
immunoprivileg
site
well
illustr
experi
show
ectop
express
myelin
basic
protein
mbp
mous
liver
protect
autoimmun
neuroinflamm
involv
regulatori
cell
addit
regulatori
cell
treg
found
numer
function
defect
human
aih
pool
sera
six
mice
submit
treatment
dilut
indic
materi
method
ad
elisa
well
valu
mean
serum
dilut
reach
od
b
level
ast
sera
six
anim
condit
determin
normal
control
valu
ul
depend
sampl
use
statist
signific
comparison
padr
treatment
calcul
use
mannwhitney
utest
p
b
p
b
c
uric
acid
assay
pool
sera
six
mice
triplic
statist
signific
calcul
student
test
p
b
p
b
p
b
control
sera
untreat
mice
pool
sera
six
mice
submit
treatment
use
detect
western
blot
assay
protein
concentr
calcul
densitometri
comparison
posit
control
recombin
human
hmgbiotech
srl
milano
itali
nd
detect
howev
control
could
inhibit
nonspecif
activ
innat
immun
tolllik
receptor
moreov
report
uric
acid
could
amplifi
humor
immun
respons
variou
tolllik
receptor
associ
inhibit
treg
may
bind
alarmin
heat
shock
protein
chromatin
thu
possibl
alarmin
releas
effect
mhv
padr
could
bind
tolllik
receptor
indirectli
inhibit
treg
induc
aih
sign
conclus
mhv
infect
alon
capabl
caus
hepat
associ
transient
hypergammaglobulinemia
elev
transaminas
autoab
direct
differ
liver
protein
mice
sign
reminisc
aih
addit
padr
administr
intensifi
effect
viral
infect
prolong
hypergammaglobulinemia
increas
autoab
reactiv
well
hepat
infiltr
state
vergani
mielivergani
ideal
model
aih
welldefin
initi
event
follow
chronic
inflamm
lead
fibrosi
therefor
first
part
object
reach
sinc
present
result
demonstr
infect
suscept
individu
hepatotrop
viru
trigger
aih
sign
moreov
sinc
administr
padr
adjuv
seem
expand
mhv
effect
one
specul
simpl
vaccin
infect
genet
vulner
person
may
eventu
initi
ill
nevertheless
chronic
phase
diseas
well
fibrosi
normal
found
liver
aih
patient
still
lack
model
although
effort
need
achiev
goal
find
indic
simpl
infect
viru
instead
complex
natur
protocol
immun
may
simul
onset
ill
contribut
studi
pathophysiolog
manuscript
work
support
grant
conicet
universidad
de
bueno
air
argentina
